Hydroxychloroquine Use Is Associated with a Lower Risk of Major Adverse Cardiovascular Events in Medicare Recipients with Rheumatoid Arthritis

被引：0
|
作者：
Iyer, Priyanka [1 ]
Gao, Yubo [2 ]
Girotra, Saket [2 ]
Curtis, Jeffrey [3 ]
Vaughan-Sarrazin, Mary [1 ]
Singh, Namrata [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1891
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Cardiac Rehabilitation Participation is Associated With Lower Risk of Major Adverse Cardiovascular Events Across Race or Ethnicity and Income
    Garfein, Joshua
    Swabe, Gretchen
    Forman, Daniel E.
    Magnani, Jared W.
    CIRCULATION, 2023, 147
  • [42] Cardiovascular risk in rheumatoid arthritis: How to lower the risk?
    van Breukelen-van der Stoep, D. F.
    Klop, B.
    van Zeben, D.
    Hazes, J. M. W.
    Cabezas, M. Castro
    ATHEROSCLEROSIS, 2013, 231 (01) : 163 - 172
  • [43] Elevated triglyceride levels are associated with increased risk for major adverse cardiovascular events in statin-naive rheumatoid arthritis patients: A nationwide cohort study
    Choi, Wonsuk
    Kang, Ji-Hyoun
    Park, Ji Yong
    Hong, A. Ram
    Yoon, Jee Hee
    Kim, Hee Kyung
    Kang, Ho-Cheol
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [44] Tramadol use increases mortality and risk of major adverse cardiovascular events in rheumatoid arthritis patients: evidence from a population-based cohort study
    Gau, Shuo-Yan
    Huang, Jing-Yang
    Wei, James Cheng-Chung
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (06) : E237 - E238
  • [45] Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment
    de Thurah, Annette
    Andersen, Ina Trolle
    Tinggaard, Andreas Bugge
    Riis, Anders Hammerich
    Therkildsen, Josephine
    Botker, Hans Erik
    Bottcher, Morthen
    Hauge, Ellen-Margrethe
    RMD OPEN, 2020, 6 (01):
  • [46] RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH THE INTERLEUKIN-6 RECEPTOR INHIBITOR TOCILIZUMAB
    Rao, Vijay Udyavar
    Pavlov, Andrey
    Klearman, Micki
    Musselman, David
    Giles, Jon
    Bathon, Joan M.
    Sattar, Naveed
    Lee, Janet S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1648 - E1648
  • [47] Serum Alarmin Concentrations and Risk of Incident Major Adverse Cardiovascular Events and Heart Failure in a Multicenter, Prospective Rheumatoid Arthritis Cohort
    Johnson, Tate
    Yang, Yangyuna
    Roul, Punyasha
    Duryee, Michael
    Hunter, Carlos
    Baker, Joshua
    Sauer, Brian
    Cannon, Grant
    Joseph, Amy
    Wysham, K.
    Lenert, Aleksander
    Thiele, Geoffrey
    Poole, Jill
    Mikuls, Ted R.
    England, Bryant
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4184 - 4186
  • [48] Subclinical primary aldosteronism is associated with an increased risk of major adverse cardiovascular events
    Merabtine, Amel
    Hundemer, Gregory
    Madore, Francois
    Agharazii, Mohsen
    Goupil, Remi
    HYPERTENSION, 2024, 81
  • [49] In Rheumatoid Arthritis Incident Fractures Are Associated with an Increased Risk of Cardiovascular Events.
    Mhuircheartaigh, Orla Ni
    Crowson, Cynthia S.
    Gabriel, Sherine E.
    Roger, Veronique L.
    Melton, L. Joseph, III
    Amin, Shreyasee
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S357 - S357
  • [50] Use of low-dose quetiapine and the risk of major adverse cardiovascular events
    Hojlund, Mikkel
    Lund, Lars Christian
    Andersen, Kjeld
    Correll, Christoph U.
    Hallas, Jesper
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 87 - 88
12345